{"id":2138,"date":"2017-08-25T14:35:18","date_gmt":"2017-08-25T12:35:18","guid":{"rendered":"https:\/\/www.europlasma.com\/investisseurs-et-actionnaires\/espace-actionnaires\/"},"modified":"2022-05-03T11:36:13","modified_gmt":"2022-05-03T09:36:13","slug":"espace-actionnaires","status":"publish","type":"page","link":"https:\/\/www.europlasma.com\/en\/investisseurs-et-actionnaires\/espace-actionnaires\/","title":{"rendered":"Shareholders section"},"content":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;left-t-right&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; el_class=&#8221;bloc-neg&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;4\/6&#8243;]<div id=\"ultimate-heading-88446af2fd4940004\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-88446af2fd4940004 uvc-465 \" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-88446af2fd4940004 h2'  data-responsive-json-new='{\"font-size\":\"desktop:30px;\",\"line-height\":\"desktop:36px;\"}' ><h2 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#1e3640;margin-top:0px;margin-bottom:0px;\">DIFFERENT SHAREHOLDING METHODS<\/h2><\/div><\/div>[vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;1px&#8221; el_class=&#8221;margin-20-0-0&#8211;20&#8243;]<div id=\"ultimate-heading-38676af2fd4940033\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-38676af2fd4940033 uvc-5057 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-38676af2fd4940033 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:30px;margin-bottom:0px;\">YOU HAVE THE CHOICE BETWEEN SEVERAL METHODS<br \/>\nFOR HOLDING YOUR EUROPLASMA SHARES.<\/div><\/div><div id=\"ultimate-heading-13516af2fd494004d\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-13516af2fd494004d uvc-2011 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-13516af2fd494004d .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\"><strong>&#8220;Bearer&#8221;<\/strong>: Your securities are registered with the financial intermediary of your choice. This system which allows you to group together all the securities in your portfolio within the same account, does not enable Europlasma to identify you.<\/p>\n<p><strong>&#8220;Registered&#8221;<\/strong>: Your securities are registered with Europlasma. You are therefore known by name and registered with the company, which enables you to benefit from a more personalised service.<\/div><\/div>[\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;right-t-left&#8221; width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;440&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221; el_class=&#8221;img-neg-zindex&#8221;][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;left-t-right&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;444&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221; el_class=&#8221;img-neg-zindex&#8221;][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;right-t-left&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; el_class=&#8221;bloc-neg-left&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;4\/6&#8243;][vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;1px&#8221; el_class=&#8221;margin-20-0-0&#8211;20&#8243;]<div id=\"ultimate-heading-53076af2fd4940063\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-53076af2fd4940063 uvc-7254 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-53076af2fd4940063 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:30px;margin-bottom:0px;\">THERE ARE TWO METHODS FOR REGISTRATION :<\/div><\/div><div id=\"ultimate-heading-12496af2fd4940078\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-12496af2fd4940078 uvc-6618 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-12496af2fd4940078 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\"><strong>Directly registered<\/strong> : your shares are registered and kept in your name within Europlasma&#8217;s record. The company delegates the management of this to Caceis Corporate Trust.<\/p>\n<p><strong>Administered registered<\/strong> : your shares are registered with a financial establishment which assures the management of your securities account and remains your main point of contact. In order for your shares to be registered, your custodian account holder will inform the Caceis Corporate Trust of any changes which will affect your assets and\/or your contact details. You are therefore known to the company.<\/div><\/div>[\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/6&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1503669443790{margin-top: 90px !important;margin-bottom: 70px !important;}&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/1&#8243;][vc_separator sep_color=&#8221;color-dfgh&#8221; icon_position=&#8221;left&#8221; el_width=&#8221;60px&#8221; el_height=&#8221;2px&#8221;]<div id=\"ultimate-heading-74516af2fd494008c\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-74516af2fd494008c uvc-9601 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-74516af2fd494008c .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:30px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:30px;margin-bottom:0px;\">The rules referred to above apply to all holders of transferable securities whether they are French nationals or from abroad. A person residing abroad must therefore ask the company or a qualified intermediary to register his securities in his name.<\/p>\n<p>In order that the vote expressed for the securities concerned may be taken into account, the intermediary needs to declare itself as the &#8220;registered intermediary&#8221; when any accounts are opened, by disclosing its capacity as the intermediary holding securities on behalf of others.<\/div><\/div>[vc_accordion active_tab=&#8221;active&#8221; el_class=&#8221;toggle-avantages&#8221;][vc_accordion_tab title=&#8221;ADVANTAGES AND DISADVANTAGES OF DIFFERENT SHAREHOLDING METHODS&#8221; tab_id=&#8221;1503667837-1-8&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-91306af2fd49400a0\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-91306af2fd49400a0 uvc-8684 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-91306af2fd49400a0 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table style=\"width: 100%;\" border=\"0\">\n<tbody>\n<tr>\n<td valign=\"top\"><\/td>\n<td style=\"text-align: center; background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Directly<br \/>\nregistered<\/strong><\/td>\n<td style=\"text-align: center; background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Adminitered<br \/>\nregistered<\/strong><\/td>\n<td style=\"background-color: #bbbbbb;\" align=\"center\" valign=\"middle\"><strong>Bearer<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Free of general managment fees<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"top\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #bbbbbb;\" align=\"left\" valign=\"middle\"><strong>Receipt of General Meeting convening notices and prepartory documents by post<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Registration of securities in a PEP<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Double voting rights (article 12 of the Articles of Association)<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left; background-color: #bbbbbb;\" valign=\"middle\"><strong>Single portfolio<\/strong><\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\">no<\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<td style=\"border: #bbbbbb 1px solid;\" valign=\"middle\">\n<p style=\"text-align: center;\"><strong>yes<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;HOW TO TRANSFER YOUR SHARES TO REGISTERED&#8221; tab_id=&#8221;1503667837-2-0&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-63336af2fd49400b4\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-63336af2fd49400b4 uvc-3822 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63336af2fd49400b4 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><strong>Directly registered :<\/strong><\/p>\n<p>Simply send the application form for transferring securities to your financial intermediary, duly completed and signed. Your financial intermediary will do what is necessary with the Caceis Corporate Trust (14 rue Rouget de Lisle &#8211; 92189 Issy les Moulineaux).<\/p>\n<p>On receipt of your shares, the Caceis Corporate Trust, a company appointed by Europlasma to manage the registered accounts, will send you the registration certificate for the corresponding account. The Caceis Corporate Trust will therefore become your sole point of contact for your Europlasma securities.<\/p>\n<p>A purchase\/sale advice will also be sent to you after each transaction carried out on your accont. On 31 December of each year, the Caceis Corporate Trust will send you a statement of account of your securities. The fees incurred for the transfer of securities are determined by your financial intermediary. You must therefore refer to the commissions scale applied by them.<\/p>\n<p>To find out the period of time necessary for the transfer of your securities, contact you fiancial intermediary. Registration to a registered account will only be definitive following the effective transfer of your securities by this financial intermediary.<\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;]<div id=\"ultimate-heading-99946af2fd49400c7\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-99946af2fd49400c7 uvc-604 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-99946af2fd49400c7 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:12px;\",\"line-height\":\"desktop:18px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:normal;font-style:normal;color:#6e6868;margin-top:0px;margin-bottom:0px;\"><strong>Administered registered :<\/strong><\/p>\n<p>the shares, held and managed by the shareholder&#8217;s financial intermediary, are also registered with the company&#8217;s securities service (methods particularly recommended where a PEP is held).<\/p>\n<p>Registration of these shares to administered registered does not require the securities to be transferred, or the banking institution to be changed. Your administered registered securities account is therefore managed by the financial institution of your choice.<\/p>\n<p>Your bank manager must complete a registration application (BRN: registered reference note) with Europlasma&#8217;s trustee, i.e. the Caceis Corporate Trust, and will maintain the management of your securities account.<\/p>\n<p>The Caceis Corporate Trust shall proceed with the registration of your securities to adminitered registered, free of charge, on receipt of the application by your financial intermediary. Shares held in a PEP may be registered ad administered registered.<\/div><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1505210945744{padding-top: 80px !important;padding-bottom: 80px !important;}&#8221; row_name=&#8221;assembleesgenerales&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; width=&#8221;1\/1&#8243;]<div id=\"ultimate-heading-9676af2fd49400db\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-9676af2fd49400db uvc-4712 margin-0\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-9676af2fd49400db h2'  data-responsive-json-new='{\"font-size\":\"desktop:30px;\",\"line-height\":\"desktop:36px;\"}' ><h2 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#1e3640;margin-top:0px;margin-bottom:0px;\">GENERAL MEETINGS<\/h2><\/div><\/div>[vc_accordion el_class=&#8221;toggle-assemblees&#8221; active_tab=&#8221;active&#8221;][vc_accordion_tab title=&#8221;Ordinary &amp; Extraordinary General Meeting &#8211; 7 June 2022&#8243; tab_id=&#8221;1651569987371-14-0&#8243;]<div id=\"ultimate-heading-44656af2fd49400f4\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-44656af2fd49400f4 uvc-3622 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-44656af2fd49400f4 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-44656af2fd49400f4 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of June 7, 2022. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting. <a href=\"https:\/\/www.europlasma.com\/investisseurs-et-actionnaires\/espace-actionnaires\/assemblees-generales\/\" target=\"_blank\" rel=\"noopener\">See all documentation<\/a><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary General Meeting of Shareholders on 8 June 2021 reconvened on 29 June 2021&#8243; tab_id=&#8221;1619164541461-13-6&#8243;]<div id=\"ultimate-heading-75906af2fd4940109\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-75906af2fd4940109 uvc-9311 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75906af2fd4940109 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75906af2fd4940109 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of June 8, 2021. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting.<\/div><\/div><div id=\"ultimate-heading-56376af2fd494011e\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-56376af2fd494011e uvc-1976 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-56376af2fd494011e h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-56376af2fd494011e .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2101195.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210518_CP_Mise-\u00e0-disposition-documents_AGO-du-08-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-brochure-de-convocation_AGO-08.06.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholder (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2102818.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-R\u00e9solutions_AGO-08.06.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2020 Company report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-de-gestion-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">complementary board report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-compl\u00e9mentaire-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">special board report on bonus shares<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-AGA-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-75726af2fd4940132\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-75726af2fd4940132 uvc-6099 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75726af2fd4940132 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75726af2fd4940132 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 FY2020 parent company accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RCA-CoCAC-27.04.2021..pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on FY2020 consolidated accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RCC-CoCAC-27.04.2021..pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON REGulated agreements<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-SA-2020-RS-CoCAC-27.04.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-59966af2fd4940147\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-59966af2fd4940147 uvc-6590 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-59966af2fd4940147 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-59966af2fd4940147 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance-AGO-EUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Answers to writtent questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGO-29-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation OF the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_29-06-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">minutes of the general meeting &#8211; 29\/06\/2021<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210629-EP-CR-AG.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting &#8211; 21\/06\/2021<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210608-EP-CR-AG-projet-carence.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting of Shareholders &#8211; 24\/02\/2021&#8243; tab_id=&#8221;1611128617920-12-6&#8243;]<div id=\"ultimate-heading-94376af2fd494015c\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-94376af2fd494015c uvc-4076 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-94376af2fd494015c h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-94376af2fd494015c .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of February 24, 2021. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to this General Meeting.<\/div><\/div><div id=\"ultimate-heading-22466af2fd4940171\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-22466af2fd4940171 uvc-2333 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-22466af2fd4940171 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-22466af2fd4940171 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-2_annonce-2100047.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210119_Convocation-AGE-24-f\u00e9vrier.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Ad hoc agent appointment (Press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20210215_D\u00e9signation-mandataire-AGE-24_02_2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AD HOC Certificate<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Attestation-EP-Mandataire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-de-convocation_SUD-OUEST.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-R\u00e9solutions_AGE-24.02.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210224-EP-Rapport-CA-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-83336af2fd4940185\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-83336af2fd4940185 uvc-383 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-83336af2fd4940185 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-83336af2fd4940185 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-co-CAC_1\u00e8re-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Complementary report<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-_-Rapport-compl\u00e9mentaire-co-CAC_Emission-actions-et-VM-supp-DPS-au-profit-dune-personne-d\u00e9sign\u00e9e.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-63956af2fd494019a\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-63956af2fd494019a uvc-2393 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63956af2fd494019a h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63956af2fd494019a .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote_AGE_24.02.2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Written questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGE-24-02-2021.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation OF the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_24-02-2021-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/210224-EP-CR-AGE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 28\/12\/2020&#8243; tab_id=&#8221;1606142230080-14-0&#8243;]<div id=\"ultimate-heading-28776af2fd49401b4\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-28776af2fd49401b4 uvc-4725 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-28776af2fd49401b4 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-28776af2fd49401b4 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of December 28, 2020. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to the General Meeting of December 28, 2020.<\/div><\/div><div id=\"ultimate-heading-85626af2fd49401c9\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-85626af2fd49401c9 uvc-1377 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-85626af2fd49401c9 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-85626af2fd49401c9 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/annonce-2004589.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Participation and vote (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/2020_11_-20-Convocation-AGE-28-d\u00e9cembre.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Appointment of an ad hoc representative (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201209_Designation-mandataire-AGE-28_12_2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Terms for documentation availability and participation (press release)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20201211_CP_Mise-\u00e0-disposition-documents_AGE-du-28-12-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">certificate of ad hoc representative<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201228_Attestation_EP_-_Mandataire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis_de_convocation_AGM-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AGENDA and TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Ordre-du-jour-et-texte-des-projets-de-r\u00e9solutions.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201120-EP-Rapport-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-32486af2fd49401dd\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-32486af2fd49401dd uvc-9632 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-32486af2fd49401dd h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-32486af2fd49401dd .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b02<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b03<\/td>\n<td style=\"text-align: right; width: 21.3412%;\">\u00a0<a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b04<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CAC_R\u00e9solution_4.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-64726af2fd49401f1\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-64726af2fd49401f1 uvc-4364 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-64726af2fd49401f1 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-64726af2fd49401f1 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/201228-EP-CR-AGE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Written questions from Shareholders<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-et-r\u00e9ponses-AGE-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">How to access the recording<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rediffusion-AGE-28-12-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upolad<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and Extraordinary General Meeting &#8211; 31\/08\/2020 reconvened on 22\/09\/2020 and 28\/10\/2020 (postponed)&#8221; tab_id=&#8221;1595861352639-13-5&#8243;]<div id=\"ultimate-heading-36346af2fd4940205\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-36346af2fd4940205 uvc-1861 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-36346af2fd4940205 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-36346af2fd4940205 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\">In view of the uncertainties resulting from the current context linked to Covid-19, the Company could be led to modify, in accordance with legal and regulatory provisions, the place, the form as well as the terms of conducting, participation and voting in the General Meeting of August 31, 2020. If applicable, the final terms of the General Meeting will be specified on this section In any event, we invite you to regularly consult this page to keep you informed of news and final terms relating to the General Meeting of August 31, 2020.<\/p>\n<p><\/div><\/div><div id=\"ultimate-heading-63886af2fd4940219\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-63886af2fd4940219 uvc-1883 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63886af2fd4940219 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63886af2fd4940219 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-R\u00e9union-BALO_27-07-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Convocation_AGOE_31-08-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_2\u00e8me-\u00e9preuve-BALO-annonce-2003917.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (3rd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO_3\u00e8me-convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice of postponement<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Epreuve-BALO-annonce-2004344.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Texte-des-projets-de-r\u00e9solutions-AGM-31-08-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON general meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 Company report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-de-gestion-2019-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-comptes-sociaux-31-12-19.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2019 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-comptes-conso-31-12-19.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-36026af2fd494022e\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-36026af2fd494022e uvc-368 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-36026af2fd494022e h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-36026af2fd494022e .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON\u00a0 parent Company accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RCA-CoCAC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on consolidated accounts<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RCC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON regulated agreements<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EUROPLASMA-2019-RS-CoCAC-26.04.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b06<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_6\u00e8me-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-du.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b07<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_7\u00e8me-r\u00e9solution_Emission-actions-et-VM-supp-DPS-au-profit-de-cat\u00e9gories-de-.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b08<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_8\u00e8me-r\u00e9solution_augmentation-de-capitaml-adh\u00e9rents-PEE_31.07.2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b09<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-2020-Rapport-Co-CAC_9\u00e8me-r\u00e9solution_r\u00e9duction-de-capital-par-annulation-dactions-Art-L.225.20.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-20186af2fd4940242\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-20186af2fd4940242 uvc-7313 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-20186af2fd4940242 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-20186af2fd4940242 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy (valid for the second call)<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-par-correspondance-AG-EUROPLASMA-du-31.08.20.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Pr\u00e9sentation-AG_22-09-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the General meeting (ordinary part)<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/RESULTAT-CONSOLIDE-DU-VOTE-RESOLUTION-PAR-RESOLUTION_AGO.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting HELD on 31\/08\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/200831-EP-PV-AGM.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the general meeting held on 22\/09\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/200922-EP-PV-AG-internet.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 06\/04\/2020 reconvened on 27\/04\/2020&#8243; tab_id=&#8221;1582882626346-12-2&#8243;]<div id=\"ultimate-heading-37786af2fd4940256\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-37786af2fd4940256 uvc-3515 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-37786af2fd4940256 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">Covid-19 information<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-37786af2fd4940256 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<p style=\"text-align: left;\">In the context of the Covid-19 epidemic and in accordance with the measures taken by the government to stop the virus epidemic, the Board of Directors decided to exceptionally hold the general meeting behind closed doors.<\/p>\n<p style=\"text-align: left;\">Shareholders are therefore invited to submit their questions in writing to <a href=\"mailto:contact@europlasma.com\">contact@europlasma.com<\/a> and to use distance voting means. The practical details are specified in the <a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20200406_Compte-rendu-AGE-Europlasma.pdf\">press release dated April 6, 2020.<\/a> (in French)<\/p>\n<p style=\"text-align: left;\">The proxy or postal voting forms received by the company for the meeting of April 6, 2020 remain valid for the meeting of April 27, 2020. For shares held in bearer form, a new conforming bank certificate must be provided.<\/p>\n<p><\/div><\/div><div id=\"ultimate-heading-65886af2fd4940269\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-65886af2fd4940269 uvc-8061 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-65886af2fd4940269 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-65886af2fd4940269 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-r\u00e9union_AGE_06-04-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis-de-convocation-AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/2\u00e8me-Epreuve-BALO.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Texte-des-resolutions-AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport-CA_AGE-06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-82636af2fd494027d\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-82636af2fd494027d uvc-8216 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-82636af2fd494027d h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-82636af2fd494027d .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON\u00a0 Resolution N\u00b01<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b01.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on resolution n\u00b02<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-AGE-6-04-2020-Rapport-des-cac-sur-le-regroupement-dactions-non-admises-aux-n\u00e9gociations-sur-un-march\u00e9-reglement\u00e9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">REPORT ON Resolution n\u00b03<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b03.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">Report on\u00a0 resolution n\u00b04<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-6-AVRIL-2020-R\u00e9solution-\u00b04.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 68.2422%;\">report on resolution n\u00b0<\/td>\n<td style=\"text-align: right; width: 21.3412%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-Rapport-CAC-AGE-06-AVRIL-2020-R\u00e9solution-n\u00b05.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-74236af2fd4940291\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-74236af2fd4940291 uvc-277 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-74236af2fd4940291 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-74236af2fd4940291 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-universel-AGE-EUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 06\/04\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/20200406_PRESENTATION_AG_06-04-2020-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">presentation showed during the general meeting on 27\/04\/2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AG_27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the EGM<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultats-du-vote-r\u00e9solution-par-r\u00e9solution_AGE-27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the EGM of 6 april 2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV-carence_AGE_06-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Mintues of the EGM of 27 APRIL 2020<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV-AGE_27-04-2020.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary General Meeting &#8211; 29\/11\/2019 reconvened on 20\/12\/2019&#8243; tab_id=&#8221;1571835876126-11-4&#8243;]<div id=\"ultimate-heading-15216af2fd49402a7\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-15216af2fd49402a7 uvc-3529 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-15216af2fd49402a7 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-15216af2fd49402a7 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-AVIS-DE-REUNION_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-convocation_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_avis-de-seconde-convocation_BALO-du-09_12_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-et-Texte-des-Resolutions_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/191113-EP-RG-int%C3%A9grant-rapp.-gvt-entreprise.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD REPORT ON OGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_du_CA_\u00e0_l_AGO_29_11_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds in favor ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire_%C3%A9mission_conversion_T4-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds with warrants attached in favour ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_Rapport_compl%C3%A9mentaire_CA_BEOCABSA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on zigi capital debt compensation<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire___cr%C3%A9ance_obligataire-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">board report on issuance of convertible bonds in favor zigi capital<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_rapport_compl%C3%A9mentaire_CA_-_Zigi-081119.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">fy2018 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-aux-comptes-annuels-Europlasma-au-31-12-18-DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">fy2018 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Annexe-conso-31-12-18-DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-70096af2fd49402bc\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-70096af2fd49402bc uvc-2525 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-70096af2fd49402bc h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-70096af2fd49402bc .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON\u00a0 FY2018 ANNUAL ACCOUNTS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RCA-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON FY2018 CONSOLIDATED ACCOUNTS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2019\/11\/EUROPLASMA-Rapport-des-CAC-Cptes-Consolides-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">special report on\u00a0 regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RS-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on zigi capital debt compensation<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-COMPENSATION-CREANCE-ZIGI-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on convertible bonds issuance in favor of eghos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCA-ABO-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on issuance of convertible bonds with warrants attached in favor of ehgos<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCABSA-ABO-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">supplementary report on convertible bonds issuance in favor of zigi capital<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-RAPPORT-CPLT-OCABSA-ZIGI-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">cERTIFICATION OF REMUNERATIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-ATTESTATION-REMUNERATIONS-2019-11-13.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-23316af2fd49402d0\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-23316af2fd49402d0 uvc-3176 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-23316af2fd49402d0 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-23316af2fd49402d0 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Formulaire-de-vote-de-lAGO-dEUROPLASMA.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">written questions<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-\u00e9crites-AG-29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/191119PRESENTATION_AG_20-12-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Voting RESULTS of the meeting held on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/R\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minutes of the OGM on 20\/12\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_PV_AG_20_12_2019_executed.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">minuteS OF THE ogm on 29\/11\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_PV_AGO_29-11-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and extraordinary General Meeting of Shareholders &#8211; 20\/08\/2019 reconvened on 03\/09\/2019&#8243; tab_id=&#8221;1562060415991-10-2&#8243;]<div id=\"ultimate-heading-48176af2fd49402e4\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-48176af2fd49402e4 uvc-5258 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-48176af2fd49402e4 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-48176af2fd49402e4 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice of shareholder&#8217;s meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_ARAC-BALO-du-15-juillet-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1st CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Avis_de_convocation_AGOE_20_08_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">notice to convene the meeting of shareholders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/annonce-1904216.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Texte_des_resolutions_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Expos\u00e9_sommaire_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_du_CA_AGOE_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-1496af2fd49402f7\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-1496af2fd49402f7 uvc-7440 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-1496af2fd49402f7 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-1496af2fd49402f7 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON 4th RESOLUTION<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-Rapport-r\u00e9duction-capital-4\u00e8me-r\u00e9so.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON 6th and 9th RESOLUTIONs<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-260719-Rapport-Co-Cac-R\u00e9solutions-6-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th, 7th and 9th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-260719-RAPPORT-CO-CAC-offre-au-public-r\u00e9sos-6-7-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th, 8th and 9th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-r\u00e9solutions-6-8-et-9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 10th resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-R\u00e9solution-10.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">report on 6th and 11th resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/SE-EP-200819-Rapport-Co-Cac-R\u00e9solution-6-et-11.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-80416af2fd494030c\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-80416af2fd494030c uvc-9399 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-80416af2fd494030c h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-80416af2fd494030c .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Blank proxy<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_formulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Access map<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the General Meeting on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"http:\/\/&lt;i class=&quot;fa fa-download&quot; aria-hidden=&quot;true&quot;&gt;&lt;\/i&gt;\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">quorum details of the meeting held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/quorum-d\u00e9finitif.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">RESULTS OF THE ogm held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/r\u00e9sultat-consolid\u00e9-du-vote-r\u00e9solution-par-r\u00e9solution.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minute of the OGM held on 20\/08\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AGEO_20-08-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Presentation showed during the general meeting on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AG_03-09-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">quorum details of the meeting held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_-_Quorum_d\u00e9finitif_03_09_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">results of the egm held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Europlasma_-_R\u00e9sultat_consolid\u00e9_du_vote_r\u00e9solution_par_r\u00e9solution_-_03_09_2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase; width: 95.2912%;\">Minute of the EGM held on 03\/09\/2019<\/td>\n<td style=\"text-align: right; width: 10%;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AGE_03-09-2019.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordianry General Meeting of Shareholders &#8211; 25 February 2019&#8243; tab_id=&#8221;1528192625002-9-7&#8243;]<div id=\"ultimate-heading-90506af2fd4940320\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-90506af2fd4940320 uvc-3286 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-90506af2fd4940320 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-90506af2fd4940320 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/BALO-epreuve-annonce-1900040.pdf\" target=\"_blank\" rel=\"noopener\">Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-67116af2fd4940334\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-67116af2fd4940334 uvc-5182 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-67116af2fd4940334 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-67116af2fd4940334 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">AUDITORS REPORT<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-86856af2fd4940347\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-86856af2fd4940347 uvc-8625 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-86856af2fd4940347 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-86856af2fd4940347 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of THE genEral meeting<\/td>\n<td style=\"text-align: right;\">Not yet available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;General Meeting of Shareholders &#8211; 21 June 2018 reconvened on 27 September 2018&#8243; tab_id=&#8221;1557215380409-10-3&#8243;]<div id=\"ultimate-heading-85796af2fd494035b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-85796af2fd494035b uvc-9545 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-85796af2fd494035b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-85796af2fd494035b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/AVIS_REUNION_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (2nd CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-BALO-2de-convocation-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ODJ-Texte_Resolutions_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Expose_Sommaire_AG-21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CA_AGE_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">&#8220;dOCUMENT DE R\u00c9F\u00c9RENCE&#8221; 2017 including the annual financial report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/DDR2017ALEUP.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-40286af2fd494036f\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-40286af2fd494036f uvc-8362 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-40286af2fd494036f h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-40286af2fd494036f .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Certificatie ON REmuneration<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-Attestation-CAC-r\u00e9mun\u00e9rations-vers\u00e9es.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b09<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s9-Rapport-CAC-r\u00e9duction-capital.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b011 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s11-15-Rapport-CAC-\u00e9mission-actions-et-VM-maintien-DPS.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b014 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s14-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-au-profit-de-categories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b012 and n\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s12-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-offre-au-public.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b014 and N\u00b015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s14-15-Rapport-CAC-\u00e9mission-actions-et-VM-supp-DPS-au-profit-de-categories-de-b\u00e9n\u00e9ficiaires.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b0 16<\/td>\n<td style=\"text-align: right;\">\u00a0<a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP-18-06-21-R\u00e9s16-Rapport-CAC-aug-capital-r\u00e9serv\u00e9e-aux-adh\u00e9rent-PEE.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-91946af2fd4940383\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-91946af2fd4940383 uvc-9442 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-91946af2fd4940383 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-91946af2fd4940383 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_formlulaire-de-vote-par-correspondance.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Procedure-vote-actionnaires-au-porteur-AG-21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">JEAN-ERIC PETIT PROFILE<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV_JEP_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">francois bonnin profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV-Fran\u00e7ois-Bonnin.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">olivier ricart profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/CV_O-RICART.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to written questions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Reponses-Questions-ecrites_AG-27-09-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 21\/06\/2018<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_21-06-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of general meeting of 27\/09\/2018<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PV_AG_27-09-2018.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;General Meeting of Shareholders &#8211; 10\/10\/2017 reconvened on 26\/10\/2017&#8243; tab_id=&#8221;1505204903962-7-0&#8243;]<div id=\"ultimate-heading-86266af2fd4940397\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-86266af2fd4940397 uvc-7695 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-86266af2fd4940397 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-86266af2fd4940397 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_reunion_balo_04-09-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (1ST CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/1704518_epreuve_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">NOTICE TO CONVENE THE MEETING OF SHAREHOLDERS (2ND CALL)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-2eme-convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">TEXT OF RESOLUTIONS<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_TR_AGE_10-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">BOARD OF DIRECTORS REPORT ON EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EP_Rppt_AGE_activite.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-87526af2fd49403ab\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-87526af2fd49403ab uvc-3397 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-87526af2fd49403ab h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-87526af2fd49403ab .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION n\u00b01<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolution_1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b03 and 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_3-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b04 and 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_4-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b05 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_5-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b06 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_6-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b07 to 8<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolutions_7-8.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">REPORT ON RESOLUTION\u00a0n\u00b0 9<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Rapport_CAC_Resolution_9.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-14936af2fd49403be\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-14936af2fd49403be uvc-7911 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-14936af2fd49403be h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-14936af2fd49403be .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA_Formulaire-de-vote-vierge.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">How to vote for bearers ?<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Porc\u00e9dure-vote-actionnaires-au-porteur-AGE-oct-2017_DEF.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">THE COMPANY DECIDES NOT TO COMPLY WITH A REQUEST FOR REGISTRATION OF A DRAFT RESOLUTION, THE LEGAL CONDITIONS HAVE NOT BEEN MET. HOWEVER, THE COMPANY WISHES TO REPLY IN COMPLETE AND DETAILED MANNER AND TO PUT THE CONTENT OF ITS RESPONSE ON-LINE IN THE INTERESTS OF ALL SHAREHOLDERS.<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Reponse_courrier_actionnaire.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to questions from shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/Questions-R\u00e9ponses_AGE_26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/PRESENTATION_AGE_26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 26\/10\/2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/RESULTATS_AGE-26-10-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minute of General Meeting of 10 October 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/EUROPLASMA-PV-AGE-DE-CARENCE-10-octobre-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Ordinary and extraordinary General Meeting of Shareholders &#8211; 15\/06\/2017 reconvened on 29\/06\/2017&#8243; tab_id=&#8221;1504002901701-6-9&#8243;]<div id=\"ultimate-heading-19056af2fd49403d3\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-19056af2fd49403d3 uvc-1153 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-19056af2fd49403d3 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-19056af2fd49403d3 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_reunion_ag_ep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Corrigendum to the notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_convocation_ag_ep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareloders (2nd call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte-resolutions-2012.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte_reso_ag_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors of the OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ca_age_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2016 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/compte_sociaux_31-12-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2016 consolidated account<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_conso_31-12-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2016 Registration Document including Financial Annual Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ddr_2016_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-78956af2fd49403e7\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-78956af2fd49403e7 uvc-3039 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-78956af2fd49403e7 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-78956af2fd49403e7 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2016 parent company accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_cptes-annuels_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2016 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_cptes-conso_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_spe_conventions-reglementees_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Complementary report on the issue of OCABSA<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_complementaire_cac_ocabsa.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution n\u00b07<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_7.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 10 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_10-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution\u00a011 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_11-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 12 to 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_12-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution 13 and 14<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_13-14.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on Resolution\u00a015<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_rapport_cac_reso_15.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-63196af2fd49403fb\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-63196af2fd49403fb uvc-9347 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63196af2fd49403fb h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\"> OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-63196af2fd49403fb .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy (valid for the AGM of 29\/06\/2017)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_vpc_agm15-06-17_vierge.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Erik Martel profile<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/erik_martel_curriculum_vitae.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Answers to questions from shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/questions-rponses_ag_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 15 June 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/pv_agep_15-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Minutes of General Meeting of 29 June 2017<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/ep_pv_ago_29-06-2017.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Extraordinary General Meeting &#8211; 02\/09\/2016&#8243; tab_id=&#8221;1503670629-2-27&#8243;]<div id=\"ultimate-heading-87926af2fd494040f\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-87926af2fd494040f uvc-2195 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-87926af2fd494040f h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-87926af2fd494040f .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_age_27-07-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_convocation_age_12-08-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/age_texte-resolution_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors to the EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ca_age_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_recto-verso_europlasma-02_09_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-75216af2fd4940422\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-75216af2fd4940422 uvc-7256 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75216af2fd4940422 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-75216af2fd4940422 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 1st Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 2nd Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on 3rd Resolution<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_reso3.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-4046af2fd4940435\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-4046af2fd4940435 uvc-6293 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-4046af2fd4940435 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-4046af2fd4940435 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation\u00a0showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/pv_age_02-09-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Combined General Meeting &#8211; 08\/06\/2016&#8243; tab_id=&#8221;1503670629-1-82&#8243;]<div id=\"ultimate-heading-8986af2fd4940449\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-8986af2fd4940449 uvc-1432 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-8986af2fd4940449 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-8986af2fd4940449 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_avis_reunion_ag_08-06-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_ag_ep_13-05-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of Resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/texte_resolutions_agoe2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_ag2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report of Board of Directors to the OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_president_age2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2015\u00a0parent company\u00a0accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_sociaux_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY 2015 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_consolides_2015_28-04-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2015 Registration Document\u00a0including\u00a0Financial Annual Report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_ddr_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-80936af2fd494045e\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-80936af2fd494045e uvc-1255 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-80936af2fd494045e h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-80936af2fd494045e .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2015\u00a0parent company\u00a0accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_comptes_annuels_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2015 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_comptes_consolides_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/aleup_rapport_cac_conventions_reglementees_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the share capital reduction (9th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_cac_reduction_capital.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of bonus shares (10th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_attribution_actions.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of warrants with subscription rights cancelled (11th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_rapport_sup_dps.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on issuing of stock options and\/or subscription plan (12th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_options_souscription.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the issuing of common shares reserved to PEE (13th resolution)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_augmentation_capital_pee.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-67356af2fd4940472\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-67356af2fd4940472 uvc-3943 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-67356af2fd4940472 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-67356af2fd4940472 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_vpc.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Pierre Catlin&#8217;s biography<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/cv_pierre_catlin.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Yann Le Dor\u00e9&#8217;s biography<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/cv_yann_le_dore.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag-1.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation\u00a0showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/resultats_agm_08-06-2016.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][vc_accordion_tab title=&#8221;Combined General Meeting &#8211; 24\/06\/2015&#8243; tab_id=&#8221;1503999928284-3-4&#8243;]<div id=\"ultimate-heading-4376af2fd4940486\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-4376af2fd4940486 uvc-4890 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-4376af2fd4940486 h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:0px;margin-bottom:0px;\">PREPARATORY DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-4376af2fd4940486 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/balo_13_mai_2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Text of resolutions<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/odj_texte_reso_ag2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Notice to convene the Meeting of Shareholders (1st call)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/avis_convocation.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Company summary report<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/expose_sommaire_ag2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Financial results over 5 years (parent company)<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/tableau_resultats_5exercices.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">2014 report of activity<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_activite_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Board of Directors report on OGM\/EGM<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_ag_24-06-2015vdef.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2014 annual accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_sociaux_2014_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">FY2014 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/comptes_consolides_2014_aleup.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i> Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-33226af2fd494049b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-33226af2fd494049b uvc-6410 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-33226af2fd494049b h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">STATUTORY AUDITORS REPORTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-33226af2fd494049b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Information note on the reports<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/note_information.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2014 social accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_comptes_sociaux_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the FY2014 consolidated accounts<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_comptes_conso_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the regulated agreements<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_spe_cac_conv_reg_2014.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital reduction<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_reduction_k.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital increases with preferential rights maintained<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_augmentations_k.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the allocation of bonus shares<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapport_cac_aga.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Report on the capital increase reserved for employees<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/rapp_cac_aug_k_salaries.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div><div id=\"ultimate-heading-30096af2fd49404af\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-30096af2fd49404af uvc-7504 margin-0 europlasma-tables\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-30096af2fd49404af h3'  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}' ><h3 style=\"font-family:&#039;Ubuntu&#039;;font-weight:700;color:#e69731;margin-top:50px;margin-bottom:0px;\">OTHER DOCUMENTS (in French)<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-30096af2fd49404af .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:14px;\",\"line-height\":\"desktop:22px;\"}'  style=\"font-family:&#039;Ubuntu&#039;;font-weight:500;color:#727272;margin-top:0px;margin-bottom:0px;\"><\/p>\n<table class=\" aligncenter\" style=\"border: 1px solid #c4c4c4; width: 70%;\" border=\"0\" cellpadding=\"2\">\n<tbody>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Blank proxy<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/formulaire_recto_verso_europlasma.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Access map<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/plan_acces_ag-2.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Presentation showed during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/presentation_ag_24-06-2015.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">Questions and answers during the General Meeting<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/qa_agoe_24-06-2015_vdef.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify; text-transform: uppercase;\">General Meeting results<\/td>\n<td style=\"text-align: right;\"><a href=\"https:\/\/www.europlasma.com\/wp-content\/uploads\/2017\/08\/europlasma_resultats_agoe_24-06-2015b.pdf\" target=\"_blank\" rel=\"noopener\"><i class=\"fa fa-download\" aria-hidden=\"true\"><\/i>Upload<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div><\/div>[\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1536,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-invest.php","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138"}],"collection":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/comments?post=2138"}],"version-history":[{"count":174,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138\/revisions"}],"predecessor-version":[{"id":2795,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/2138\/revisions\/2795"}],"up":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1536"}],"wp:attachment":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/media?parent=2138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}